-
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Recommendation of "Moderate Buy" by Analysts
Source: Buzz FX / 26 Jan 2025 03:51:18 America/Chicago
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Recommendation of "Moderate Buy" by Analysts Written by MarketBeat January 26, 2025 Share Link copied to clipboard. 4D Molecular Therapeutics, Inc.
Read more...